157 related articles for article (PubMed ID: 3973426)
1. Expression of tumor-associated surface membrane antigens on marrow CFU-s, CFC-gm, BFU-e, and brain CFU-s.
Hasthorpe S; Bartlett PF; Rogerson J
Int J Cell Cloning; 1985 Jan; 3(1):10-21. PubMed ID: 3973426
[TBL] [Abstract][Full Text] [Related]
2. Identification of a tumor cell-derived differentiation antigen on mouse colony-forming units in the spleen and progenitor cells.
Hasthorpe S; Stokes K; Rogerson J
Cancer Res; 1985 Oct; 45(10):5042-9. PubMed ID: 4027983
[TBL] [Abstract][Full Text] [Related]
3. Surface membrane antigens of hemopoietic tumor cell lines and normal marrow progenitor cells.
Hasthorpe S; Rogerson J; McKenzie IF
Cancer Res; 1981 Oct; 41(10):3985-91. PubMed ID: 7285008
[TBL] [Abstract][Full Text] [Related]
4. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
5. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
6. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
7. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors.
Holmberg LA; Miller BA; Ault KA
J Immunol; 1984 Dec; 133(6):2933-9. PubMed ID: 6436368
[TBL] [Abstract][Full Text] [Related]
8. Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus.
Colletta G; Di Fiore PP; Fusco A; Lettieri F; Covelli A; Peschle C
Cancer Res; 1983 Feb; 43(2):598-603. PubMed ID: 6293700
[TBL] [Abstract][Full Text] [Related]
9. Antiserum to mouse hematopoietic pluripotent stem cells (CFU-S): further investigation of its functional properties.
Kuznetsky RD; Trobaugh FE; Adler SS
Exp Hematol; 1979 Aug; 7(7):369-76. PubMed ID: 488193
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the anti-stem cell activity of anti-mouse brain serum.
Monette FC; Eichacker PQ; Garver RI; Byrt W; Gilio MJ
Exp Hematol; 1978 Mar; 6(3):299-310. PubMed ID: 648593
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated surface membrane antigens on CFUs: characterization using the fluorescent activated cell sorter.
Hasthorpe S; Rogerson J
Exp Hematol; 1982 Jan; 10(1):9-19. PubMed ID: 7060662
[TBL] [Abstract][Full Text] [Related]
12. Variable expression of Qa-m7, Qa-m8, and Qa-m9 antigenic determinants on primitive hemopoietic precursor cells.
Harris RA; Sandrin MS; Sutton VR; Hogarth PM; McKenzie IF; Penington DG
J Cell Physiol; 1985 Jun; 123(3):451-8. PubMed ID: 2580849
[TBL] [Abstract][Full Text] [Related]
13. An immunologic comparison between bone marrow and spleen-derived pluripotent hemopoietic stem cells (CFU-S) of mouse : effect of rabbit anti-mouse brain serum.
Kuznetsky RD; Trobaugh FE; Adler SS
Biomedicine; 1978 Oct; 29(6):191-3. PubMed ID: 737278
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
15. Surface antigens of murine hemopoietic stem cells. I. Cross reactivity of antisera against differentiated hemopoietic cells with bone marrow stem cells.
Berridge MV; Okech N
Exp Hematol; 1979 Oct; 7(9):452-68. PubMed ID: 527692
[TBL] [Abstract][Full Text] [Related]
16. Qa-1 and Qa-2 expression on CFU-s.
Lynes MA; Tonkonogy S; Flaherty L
J Immunol; 1982 Sep; 129(3):928-30. PubMed ID: 7108211
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
18. Hemopoiesis during thiamphenicol treatment. II. A theoretical analysis shows consistency of new data with a previously hypothesized model of stem cell regulation.
Loeffler M; Bungart B; Goris H; Schmitz S; Nijhof W
Exp Hematol; 1989 Oct; 17(9):962-7. PubMed ID: 2776856
[TBL] [Abstract][Full Text] [Related]
19. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
[TBL] [Abstract][Full Text] [Related]
20. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
